The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rociletinib-associated cataracts in EGFR-mutant NSCLC.
 
Zofia Piotrowska
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology
 
Erica Liu
No Relationships to Disclose
 
Jennifer Logan
No Relationships to Disclose
 
Jessica Chow
No Relationships to Disclose
 
Fasika A Woreta
No Relationships to Disclose
 
Alona Muzikansky
No Relationships to Disclose
 
Lisa Stober
No Relationships to Disclose
 
Alexandra Carly Wanat
Consulting or Advisory Role - Clovis Oncology
 
Kelly Goodwin
No Relationships to Disclose
 
Christopher G. Azzoli
Honoraria - Boehringer Ingelheim
 
Jennifer S. Temel
Research Funding - Helsinn Therapeutics (Inst)
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Abbvie; Celgene; Debiopharm Group; Exelixis; GlaxoSmithKline; Incyte; Millennium; Mirati Therapeutics; Novartis; Peregrine Pharmaceuticals; Roche; Sanofi
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech
 
Jeffrey A. Engelman
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genentech; Novartis; Roche
Research Funding - AstraZeneca; Novartis
 
Kamden Kopani
No Relationships to Disclose
 
Lecia V. Sequist
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)